Literature DB >> 281556

Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma.

S Becker, R Kiessling, N Lee, G Klein.   

Abstract

On the basis of studies indicating that natural killer (NK) cells of the mouse can selectively kill certain syngenetic, allogeneic, and xenogeneic tumor cells in short-term Cr release assays and that cell lines established in vitro are more sensitive than the corresponding ascites tumor cells passaged in vivo, the kinetics of the modulation to increased sensitivity was studied after in vitro explanation of the A/Sn mouse-derived YAC ascites lymphoma. Sensitivity to NK lysis appeared after 3 weeks of culturing and reached the level of the continuously cultured line after 2 months. With the more sensitive competition assay, a change could be demonstrated as early as 2--24 hours of culture. The expression of the Moloney murine leukemia virus-determined, cell-surface antigen, measured by quantitative absorption with intact cells, increased in parallel with the NK sensitivity. In contrast, the H-2 alloantigen concentration decreased during in vitro culture.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 281556

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  22 in total

1.  In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

Authors:  Joëlle Riond; Stéphane Rodriguez; Marie-Laure Nicolau; Talal al Saati; Jean Edouard Gairin
Journal:  Cancer Immun       Date:  2009-11-02

Review 2.  Interleukin-10: a cytokine used by tumors to escape immunosurveillance.

Authors:  F Salazar-Onfray
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

3.  Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.

Authors:  M Ferrantini; S Pulciani; E Proietti; G Lespinats; A Anastasi; V Ciolli; P Rizza; F Belardelli
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

Review 4.  The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors:  I M Svane; M Boesen; A M Engel
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

5.  Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients.

Authors:  E Yanagawa; A Uchida; M Moore; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 6.  Tumor cells do not arise frequently.

Authors:  W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

8.  Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.

Authors:  M Ullberg; M Jondal
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

Review 9.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

10.  Rifampicin-induced suppression of antitumor immunity.

Authors:  W Roszkowski; R Lipinska; K Roszkowski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.